ETHZilla Soars 15.92% on $349M Ether Holdings

On August 13, 2025, 180 Life Sciences (ETHZilla) experienced a significant surge in its stock price, rising by 15.92% in pre-market trading.

180 Life Sciences, now operating under the name ETHZilla, has disclosed that it holds a substantial amount of Ether (ETH), totaling 82,186 tokens. This holding is valued at approximately $349 million, based on an average acquisition price of $3,806.71 per token. The company's significant investment in ETH has garnered attention and contributed to the recent surge in its stock price.

In addition to its ETH holdings, 180 Life Sciences also reported having roughly $238 million in cash. This financial strength, combined with its strategic investment in cryptocurrency, has positioned the company favorably in the market. The disclosure of these holdings has led to a sharp increase in investor interest, driving the stock price upwards.

The company's decision to hold a large amount of ETH reflects its confidence in the future of cryptocurrency and its potential for growth. This move has not only attracted investors but also highlighted the company's forward-thinking approach to financial management. As the market continues to evolve, 180 Life Sciences' strategic investments are likely to play a crucial role in its future success.